Home/Pipeline/Soft Mist Inhaler for PAH (with unnamed Pharma Partner)

Soft Mist Inhaler for PAH (with unnamed Pharma Partner)

Pulmonary Arterial Hypertension

Not DisclosedActive

Key Facts

Indication
Pulmonary Arterial Hypertension
Phase
Not Disclosed
Status
Active
Company

About Resyca

Resyca BV is a private, Netherlands-based company that has established itself as a specialist in innovative soft mist drug delivery platforms. Its core technologies, the PFSI™ (pre-filled syringe inhaler) and Pulmospray®/Ultra Soft Nasal Pump Spray systems, are designed to aerosolize liquid formulations—including sensitive biologics and high-dose drugs—for targeted lung and nasal cavity delivery. Operating as a B2B platform and development partner, Resyca collaborates with pharmaceutical companies to accelerate combination products to market, leveraging clinically validated, IP-protected devices that align with sustainability goals by avoiding propellants.

View full company profile

Other Pulmonary Arterial Hypertension Drugs

DrugCompanyPhase
Tadliq® (Tadalafil Oral Suspension)CMP PharmaApproved
Technosphere Platform (Partnered: Tyvaso DPI)MannKindApproved
JTV-161Akros PharmaPhase1
PROPHETOcclutechPilot
LTSE-2578Structure TherapeuticsPhase 1
Tyvaso DPI®MannKind CorpApproved
F230Gyre TherapeuticsNot Specified